2 blue chip ASX 200 shares that could be strong buys

If you’re aiming to build a balanced portfolio, having a few blue chip ASX shares in there could be a smart move.

But which blue chip ASX 200 shares should you buy? Two that are highly rated are listed below:

The first blue chip ASX 200 share to look at is biotechnology giant CSL.

CSL has a focus on rare and serious diseases through its CSL Behring business and influenza vaccines through its Seqirus business.

CSL Behring has a wide range of innovative therapies. These are used to treat immunodeficiencies, bleeding disorders, hereditary angioedema, Alpha 1 antitrypsin deficiency, and neurological disorders. Whereas Seqirus has a broad range of flu products meeting the needs of different populations around the world.

While…